High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders

Barry Wolf

doi:10.1016/j.ymgme.2019.07.003

High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders

Barry Wolf

Pediatrics

Research output: Contribution to journal › Comment/debate › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	321-324
Number of pages	4
Journal	Molecular Genetics and Metabolism
Volume	127
Issue number	4
DOIs	https://doi.org/10.1016/j.ymgme.2019.07.003
State	Published - Aug 1 2019

Keywords

Avidin
Biotin
Biotin interference
Biotin-responsive
Biotin-thiamine-responsive basal ganglia disease
Biotinidase deficiency
Holocarboxylase synthetase deficiency
Streptavidin

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Biochemistry
Molecular Biology
Genetics
Endocrinology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ymgme.2019.07.003

Cite this

@article{03d78c4eb86c4db19969ba1076530fc5,

title = "High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders",

keywords = "Avidin, Biotin, Biotin interference, Biotin-responsive, Biotin-thiamine-responsive basal ganglia disease, Biotinidase deficiency, Holocarboxylase synthetase deficiency, Streptavidin",

author = "Barry Wolf",

year = "2019",

month = aug,

day = "1",

doi = "10.1016/j.ymgme.2019.07.003",

language = "English (US)",

volume = "127",

pages = "321--324",

journal = "Molecular Genetics and Metabolism",

issn = "1096-7192",

publisher = "Academic Press Inc.",

number = "4",

}

TY - JOUR

T1 - High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies

T2 - Implications for individuals with biotin-responsive inherited metabolic disorders

AU - Wolf, Barry

PY - 2019/8/1

Y1 - 2019/8/1

KW - Avidin

KW - Biotin

KW - Biotin interference

KW - Biotin-responsive

KW - Biotin-thiamine-responsive basal ganglia disease

KW - Biotinidase deficiency

KW - Holocarboxylase synthetase deficiency

KW - Streptavidin

UR - http://www.scopus.com/inward/record.url?scp=85068904752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068904752&partnerID=8YFLogxK

U2 - 10.1016/j.ymgme.2019.07.003

DO - 10.1016/j.ymgme.2019.07.003

M3 - Comment/debate

C2 - 31320189

AN - SCOPUS:85068904752

SN - 1096-7192

VL - 127

SP - 321

EP - 324

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

IS - 4

ER -

High doses of biotin can interfere with immunoassays that use biotin-strept(avidin) technologies: Implications for individuals with biotin-responsive inherited metabolic disorders

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this